Chevallier, P., Chantepie, S., Huguet, F., Raffoux, E., Thomas, X., Leguay, T., Marchand, T., Isnard, F., Charbonnier, A., Maury, S., Gallego-Hernanz, M.-P., Robillard, N., Guillaume, T., Peterlin, P., Garnier, A., Rialland, F., Le Houerou, C., Goldenberg, D. M., Wegener, W. A., Béné, M.-C. and Dombret, H. (2017) “Hyper-CVAD + epratuzumab as a salvage regimen for younger patients with relapsed/refractory CD22-positive precursor B-cell acute lymphocytic leukemia”, Haematologica. Pavia, Italy, 102(5), pp. e184-e186. doi: 10.3324/haematol.2016.159905.